Latest News and Press Releases
Want to stay updated on the latest news?
-
Elmwood Park, NJ, Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and...
-
Elmwood Park, NJ, Nov. 04, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and women’s health division,...
-
Elmwood Par, NJ, Aug. 01, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., one of the largest clinical laboratories in the United States, today announced it has been selected by The IPA...
-
MIAMI, FL., July 01, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health (NASDAQ: OPK) company and one of the largest clinical laboratories in the United States, has been...
-
ELMWOOD PARK, N.J., June 07, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., along with its specialty oncology and urology division, GenPath, announce today their support of Man Cave...
-
Elmwood Park, NJ, May 17, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health company, along with its specialty women’s health division, GenPath, today announces the launch of...
-
Elmwood Park, NJ, May 02, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new...
-
ELMWOOD PARK, NJ, April 17, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company (NYSE:OPK), is pleased to announce it has been recognized by Forbes as one of America’s...
-
Elmwood Park, New Jersey, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories Inc., an OPKO Health Company (NASDAQ: OPK), today announced that they will offer flexible payment arrangements...